Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

92.92
+0.36000.39%
Volume:5.12M
Turnover:474.14M
Market Cap:234.72B
PE:13.79
High:93.45
Open:91.00
Low:90.50
Close:92.56
Loading ...

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires Live
·
36 mins ago

Moderna Says Individualized Neoantigen Therapy on Track for 2027 Potential Approval

MT Newswires Live
·
2 hours ago

BUZZ-Halozyme climbs after report co to challenge Merck over patent infringement

Reuters
·
Yesterday

Morning Brew: Nvidia-Backed CoreWeave to Acquire AI Platform Weights & Biases

GuruFocus
·
Yesterday

Here's How to Play AbbVie Stock as it Enters the Obesity Space

Zacks
·
Yesterday

Merck (MRK) Battling to Protect Key Cancer Drug as Patent Row Heats Up

TIPRANKS
·
Yesterday

Market Chatter: Merck Faces Patent Dispute Over New Keytruda Version

MT Newswires Live
·
Yesterday

Merck’s Keytruda subject of brewing patent dispute with Halozyme, WSJ says

TIPRANKS
·
Yesterday

North American Morning Briefing: Stock Futures Rising on Possible Tariff Roll Back

Dow Jones
·
Yesterday

The 10-Point: The Wall Street Journal's Guide to the Day's Top News

Dow Jones
·
Yesterday

New version of Merck's Keytruda faces possible patent battle, WSJ reports

Reuters
·
Yesterday

Is Merck & Co., Inc. (MRK) The Best Immunology Stock To Buy Now?

Insider Monkey
·
Yesterday

New version of Merck's cancer drug faces patent battle, WSJ reports

Reuters
·
Yesterday

BRIEF-New Version Of Merck's Blockbuster Cancer Drug Keytruda, Threatened By Patent Battle - WSJ

Reuters
·
Yesterday

New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle - WSJ

THOMSON REUTERS
·
Yesterday

IO Biotech Reports 2024 Business Highlights

GlobeNewswire
·
Yesterday